Novartis Investigative Site

Gosford, New South Wales 2250

0 studies enrolling now · 5 studies all time

What they study most

Acute Heart Failure, Acute Myelogenous Leukemia, Alport Syndrome, Atherosclerosis, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Focal Segmental Glomerulosclerosis, IgA Nephropathy, Immunoglobulin A Nephropathy, Refractory Leukemia

Studies at this site

• Atrasentan in Patients With Proteinuric Glomerular Diseases — Running, not enrolling
• A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML) — Completed